Adial Pharmaceuticals Inc To Provide An Update On Its Regulatory And Partnering Strategy For The United States And Europe-Call Transcript
Greetings. Welcome to Adial Pharmaceuticals business update conference call. (Operator Instructions) Please note this conference is being recorded. I will now turn the conference over to your host, David Waldman, Investor Relations. You may begin.
Good morning, and thank you for joining Adial Pharmaceuticals business update conference call. On the call with us today is Cary Claiborne, Chief Executive Officer of Adial Pharmaceuticals.
As mentioned in our conference call announcement, any participants dialing in via telephone, we encourage you to obtain the slides that will be referenced on the call which are available on the Investor Relations section of the Adial website at www.adial.com/new-events.
If you have any questions after the call or would like any additional information about the company, please contact Crescendo Communications at 212-671-1020.
Before we get started, we would like to remind everyone
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
